Master Pharmacology
for USMLE Step 1
Access 30+ high-yield questions tailored for the 2026 syllabus. Includes AI-powered explanations and performance tracking.
Core Concepts
Pharmacology for USMLE Step 1 covers drug-body interactions.
- Pharmacokinetics (ADME):
- Absorption: Bioavailability (F), first-pass metabolism.
- Distribution: Volume of Distribution (Vd = Dose/Cp). High Vd for lipid-soluble drugs. Protein binding reduces free drug.
- Metabolism: Liver (CYP450, Phase I/II). Prodrugs require activation.
- Excretion: Kidney. Clearance (Cl). Half-life (t1/2). Steady state ~4-5 t1/2.
- Kinetics: First-order (constant fraction, most drugs) vs. Zero-order (constant amount, e.g., alcohol, phenytoin).
- Pharmacodynamics:
- Receptors: Ligand-gated, G-protein, enzyme-linked, intracellular.
- Agonists/Antagonists: Agonist (activates), Antagonist (blocks). Competitive vs. Non-competitive.
- Dose-Response: Potency (left shift, less drug for effect) vs. Efficacy (max effect, higher curve).
- Therapeutic Index (TI): TD50/ED50. High TI = safer.
- Tolerance/Tachyphylaxis: Decreased drug response over time.
- Drug Interactions: PK (ADME alteration, e.g., CYP450 inducers/inhibitors) or PD (additive, synergistic, antagonistic).
- Adverse Drug Reactions (ADRs):
- Type A: Dose-dependent, predictable.
- Type B: Dose-independent, unpredictable (allergic, idiosyncratic).
- Teratogenicity: Fetal harm (e.g., ACEi, Warfarin, Isotretinoin).
Clinical Presentation
- Therapeutic Effects: Manifestations of desired drug action (e.g., lowered BP, pain relief).
- Common Side Effects: Predictable from MOA.
- Anticholinergic: Dry mouth, blurred vision, urinary retention, constipation, confusion.
- Adrenergic: Tachycardia, tremors, anxiety.
- CNS: Sedation/excitation, dizziness.
- GI: Nausea, vomiting, diarrhea.
- Drug Toxicity: Exaggerated effects or organ damage (e.g., hepatotoxicity, nephrotoxicity).
- Allergic Reactions: Rash, urticaria, anaphylaxis.
Diagnosis (Gold Standard)
Assessing drug effect, toxicity, or interaction.
- Therapeutic Drug Monitoring (TDM): Measuring plasma drug concentrations for narrow therapeutic index drugs (e.g., Lithium, Digoxin, Phenytoin, Aminoglycosides, Vancomycin).
- Clinical Assessment: Comprehensive history (meds, OTCs), physical exam, symptom evaluation.
- Laboratory & Imaging: Organ function tests (LFTs, BUN/Cr), ECG.
- Dechallenge/Rechallenge: Confirming drug role in adverse events.
Management (First Line)
Managing drug-related issues.
- Dose Adjustment: Titrate based on efficacy, side effects, patient factors (renal/hepatic function, age).
- Switch Medications: For intolerable side effects or therapeutic failure.
- Supportive Care: Symptom management.
- Specific Antidotes: Reversing overdose/toxicity (e.g., Naloxone for opioids, Flumazenil for benzodiazepines, Acetylcysteine for acetaminophen).
- Discontinuation: For severe/life-threatening ADRs.
- Patient Education: Crucial for adherence, side effect recognition.
Exam Red Flags
- Narrow Therapeutic Index Drugs: TDM, toxicity, interactions (Warfarin, Lithium, Digoxin, Phenytoin, Theophylline).
- CYP450 Interactions: Inducers (Rifampin, Phenytoin, Carbamazepine); Inhibitors (Grapefruit juice, Macrolides, Azoles, Ritonavir).
- Organ-Specific Toxicities:
- Hepatotoxicity: Acetaminophen (OD), Isoniazid, Statins, Valproic acid.
- Nephrotoxicity: Aminoglycosides, NSAIDs, ACE inhibitors, Amphotericin B, Vancomycin.
- Ototoxicity: Aminoglycosides, Loop diuretics, Cisplatin.
- Cardiotoxicity: Doxorubicin (dilated CM), Amiodarone, TCAs (QT).
- Pulmonary Fibrosis: Amiodarone, Bleomycin, Methotrexate.
- Myelosuppression: Chemo, Chloramphenicol, Methotrexate.
- Teratogenic Drugs (Pregnancy Contraindications): ACEi/ARBs, Warfarin, Isotretinoin, Methotrexate, Phenytoin, Valproic acid, Tetracyclines, Lithium, Thalidomide.
- Key Antidotes: Naloxone (opioids), Flumazenil (benzos), N-acetylcysteine (acetaminophen), Protamine (heparin), Vit K (warfarin), Fomepizole (methanol/ethylene glycol).
- MAO Inhibitors: Hypertensive Crisis (tyramine foods), Serotonin Syndrome (SSRIs, SNRIs).
Sample Practice Questions
A 45-year-old female is admitted to the hospital with methicillin-resistant Staphylococcus aureus (MRSA) cellulitis. She is started on intravenous vancomycin. After the first dose, she develops diffuse flushing, erythema, pruritus, and hypotension. Her heart rate is 105 bpm. Which of the following is the most appropriate initial management for this patient?
A 28-year-old female diagnosed with Major Depressive Disorder starts a new antidepressant medication. After 3 weeks of treatment, she reports significant improvement in her mood and energy levels. However, she also reports experiencing mild nausea, some gastrointestinal upset, and a noticeable decrease in libido with difficulty achieving orgasm. Which of the following classes of antidepressants is she most likely taking?
A 35-year-old male with a history of persistent asthma presents for follow-up. He is currently on a long-acting inhaled medication for maintenance, in addition to his as-needed short-acting beta-agonist. He reports experiencing a fine tremor in his hands and occasional palpitations, especially when he first started the new maintenance medication. His blood pressure and heart rate are mildly elevated. Which of the following is the most likely mechanism of action of his new maintenance medication?
Ready to see the answers?
Unlock All AnswersUSMLE Step 1
- ✓ 30+ Pharmacology Questions
- ✓ AI Tutor Assistance
- ✓ Detailed Explanations
- ✓ Performance Analytics